Walid L. Shaib - Concepedia

Author

Walid L. Shaib

Emory University ORCID

Also Known As

Shaib, W., Shaib, Walid, W L Shaib, W. Shaib, W.L. Shaib, Walid L Shaib, Walid L. Shaib, Walid Labib Shaib, Walid Shaib

191

Publications

5.4K

Citations

H-Index

Concepts

All Affiliations

Emory University Piedmont Cancer Institute Winship Cancer Institute The Ohio State University Fondazione IRCCS Istituto Nazionale dei Tumori

About

Walid L. Shaib is an author at Emory University specializing in oncology, medicine, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	32	2.4K
2	Cell Biology	5	5	200
3	Health Sciences	3	3	45
4	Public Health	3	3	68
5	African American Studies	1	1	35

Walid L. Shaib

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial Kohei Shitara, Mustafa Özgüroğlu, Yung‐Jue Bang, The Lancet Pembrolizumab Versus PaclitaxelGastrointestinal OncologyMedicineGastroenterologySurgery	2018	1.3K
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma Vincenzo Mazzaferro, Bassel F. El‐Rayes, Michele Droz Dit Busset, British Journal of Cancer	2018	375
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial Charles S. Fuchs, Kohei Shitara, Maria Di Bartolomeo, The Lancet Oncology First-line TherapyGastrointestinal OncologyMedicinePathologyMetastatic Gastric	2019	276
The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced‐stage cancer treated with immunotherapy Mehmet Asım Bilen, Dylan J. Martini, Yuan Liu, Cancer	2018	157
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy Mehmet Asım Bilen, Julie M. Shabto, Dylan J. Martini, BMC Cancer	2019	121
A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours Kyriakos P. Papadopoulos, Bassell F. El-Rayes, Anthony W. Tolcher, British Journal of Cancer	2017	93
Inhibition of NF-κB translocation by curcumin analogs induces G0/G1 arrest and downregulates thymidylate synthase in colorectal cancer Balney Rajitha, Astrid Belalcazar, Ganji Purnachandra Nagaraju, Cancer Letters OncologyChemoprevention StrategyMedicineTumor ImmunityCancer Cell Biology	2016	78
Incidence and Survival of Appendiceal Mucinous Neoplasms Walid L. Shaib, Michael Goodman, Zhengjia Chen, American Journal of Clinical Oncology	2015	77
A phase II study of pembrolizumab in combination with mFOLFOX6 for patients with advanced colorectal cancer. Safi Shahda, Anne M. Noonan, Tanios Bekaii‐Saab, Journal of Clinical Oncology Proficient MmrMmr StatusGastrointestinal OncologyMedicinePharmacology	2017	76
Adenocarcinoma ex-goblet cell carcinoid (appendiceal-type crypt cell adenocarcinoma) is a morphologically distinct entity with highly aggressive behavior and frequent association with peritoneal/intra-abdominal dissemination: an analysis of 77 cases Michelle D. Reid, Olca Baştürk, Walid L. Shaib, Modern Pathology	2016	68

Page 1